Literature DB >> 17194630

High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma.

Edzard Schwedhelm1, Renke Maas, Jing Tan-Andresen, Friedrich Schulze, Ulrich Riederer, Rainer H Böger.   

Abstract

The balance between nitric oxide (NO) and vasoconstrictors like endothelin is essential for vascular tone and endothelial function. L-Arginine is converted to NO and L-citrulline by NO synthase (NOS). Asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) are endogenous inhibitors of NO formation. ADMA is degraded by dimethylamino dimethylhydrolases (DDAHs), while SDMA is exclusively eliminated by the kidney. In the present article we report a LC-tandem MS method for the simultaneous determination of arginine, ADMA, and SDMA in plasma. This method is designed for high sample throughput of only 20-mul aliquots of human or mouse plasma. The analysis time is reduced to 1.6 min by LC-tandem MS electrospray ionisation (ESI) in the positive mode. The mean plasma levels of l-arginine, ADMA, and SDMA were 74+/-19 (SD), 0.46+/-0.09, and 0.37+/-0.07 microM in healthy humans (n=85), respectively, and 44+/-14, 0.72+/-0.23, and 0.19+/-0.06 microM in C57BL/6 mice. Also, the molar ratios of arginine to ADMA were different in man and mice, i.e. 166+/-50 and 85+/-22, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17194630     DOI: 10.1016/j.jchromb.2006.11.052

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  52 in total

1.  Oral supplementation with L-homoarginine in young volunteers.

Authors:  Dorothee Atzler; Mirjam Schönhoff; Kathrin Cordts; Imke Ortland; Julia Hoppe; Friedhelm C Hummel; Christian Gerloff; Ulrich Jaehde; Annika Jagodzinski; Rainer H Böger; Chi-Un Choe; Edzard Schwedhelm
Journal:  Br J Clin Pharmacol       Date:  2016-09-20       Impact factor: 4.335

2.  Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.

Authors:  Xinli Hu; Dorothee Atzler; Xin Xu; Ping Zhang; Haipeng Guo; Zhongbing Lu; John Fassett; Edzard Schwedhelm; Rainer H Böger; Robert J Bache; Yingjie Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-14       Impact factor: 8.311

3.  Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.

Authors:  Bob Siegerink; Renke Maas; Carla Y Vossen; Edzard Schwedhelm; Wolfgang Koenig; Rainer Böger; Dietrich Rothenbacher; Hermann Brenner; Lutz P Breitling
Journal:  Clin Res Cardiol       Date:  2012-10-17       Impact factor: 5.460

4.  Heat-assisted extraction for the determination of methylarginines in serum by CE.

Authors:  Thomas H Linz; Susan M Lunte
Journal:  Electrophoresis       Date:  2013-06       Impact factor: 3.535

Review 5.  The role of asymmetric and symmetric dimethylarginines in renal disease.

Authors:  Edzard Schwedhelm; Rainer H Böger
Journal:  Nat Rev Nephrol       Date:  2011-03-29       Impact factor: 28.314

6.  Low homoarginine/SDMA ratio is associated with poor short- and long-term outcome after stroke in two prospective studies.

Authors:  Chi-Un Choe; Susanne Lezius; Kathrin Cordts; Christian Gerloff; Rainer H Böger; Edzard Schwedhelm; Peter J Grant
Journal:  Neurol Sci       Date:  2019-09-03       Impact factor: 3.307

7.  Asymmetric dimethylarginine predicts survival in the elderly.

Authors:  Francesco Pizzarelli; Renke Maas; Pietro Dattolo; Giovanni Tripepi; Stefano Michelassi; Graziella D'Arrigo; Maren Mieth; Stefania Bandinelli; Luigi Ferrucci; Carmine Zoccali
Journal:  Age (Dordr)       Date:  2013-04-13

8.  Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample.

Authors:  Wolfgang Lieb; Ralf A Benndorf; Emelia J Benjamin; Lisa M Sullivan; Renke Maas; Vanessa Xanthakis; Edzard Schwedhelm; Jayashri Aragam; Friedrich Schulze; Rainer H Böger; Ramachandran S Vasan
Journal:  Atherosclerosis       Date:  2008-08-28       Impact factor: 5.162

9.  Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.

Authors:  Rainer H Böger; Lisa M Sullivan; Edzard Schwedhelm; Thomas J Wang; Renke Maas; Emelia J Benjamin; Friedrich Schulze; Vanessa Xanthakis; Ralf A Benndorf; Ramachandran S Vasan
Journal:  Circulation       Date:  2009-03-16       Impact factor: 29.690

10.  Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort.

Authors:  Renke Maas; Vanessa Xanthakis; Joseph F Polak; Edzard Schwedhelm; Lisa M Sullivan; Ralf Benndorf; Friedrich Schulze; Ramachandran S Vasan; Philip A Wolf; Rainer H Böger; Sudha Seshadri
Journal:  Stroke       Date:  2009-06-04       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.